Trevie Research

Executive Summary

Trevie Research is a San Diego-based contract research organization (CRO) founded in 2019, specializing in consulting services for small and emerging pharmaceutical companies. The company assists clients in designing and executing clinical trials to demonstrate drug safety and efficacy. As a private firm with no disclosed funding or valuation, Trevie operates in the competitive CRO market, leveraging expertise in oncology and immunology. With a lean profile and no public pipelines or FDA approvals, the company's growth hinges on winning contracts from biotech startups and navigating the complex regulatory landscape. The CRO sector benefits from increasing R&D outsourcing by pharma, but Trevie faces competition from larger, established players. Its conviction score reflects steady but niche positioning.

Upcoming Catalysts (preview)

• Q3 2026New client partnerships with emerging biotech firms in oncology/immunology60% success
• TBDExpansion of service offerings to include regulatory strategy or data management40% success
• Q4 2026Favorable FDA guidance or funding boost for small pharma clinical trials50% success